NCTN Assessment on Current Applications of Radiomics in Oncology
- PMID: 30711529
- PMCID: PMC6499656
- DOI: 10.1016/j.ijrobp.2019.01.087
NCTN Assessment on Current Applications of Radiomics in Oncology
Abstract
Radiomics is a fast-growing research area based on converting standard-of-care imaging into quantitative minable data and building subsequent predictive models to personalize treatment. Radiomics has been proposed as a study objective in clinical trial concepts and a potential biomarker for stratifying patients across interventional treatment arms. In recognizing the growing importance of radiomics in oncology, a group of medical physicists and clinicians from NRG Oncology reviewed the current status of the field and identified critical issues, providing a general assessment and early recommendations for incorporation in oncology studies.
Copyright © 2019. Published by Elsevier Inc.
Figures
References
-
- Kuo MD, Gollub J, Sirlin CB, Ooi C, Chen X. Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma. Journal of vascular and interventional radiology : JVIR 2007;18(7):821–831. - PubMed
-
- Partridge SC, Gibbs JE, Lu Y, et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR American journal of roentgenology 2005;184(6):1774–1781. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources